3
项与 Encequidar mesylate/Topotecan 相关的临床试验An Open-Label, Non-Randomized, Fixed-Sequence Study in Healthy Volunteers to Evaluate the Effect of HM30181A on the Pharmacokinetics of Digoxin
An Open-Label, Non-Randomized, Fixed Sequence Study in Healthy Volunteers to Evaluate the Effect of HM30181A on the Pharmacokinetics of Dabigatran
A Dose Regimen-Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Activity of Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies
This is a multicenter, nonrandomized, open-label, safety, tolerability and pharmacokinetic (PK) study to determine the MTD and optimal dosing of Oratopo. No control group has been included.
100 项与 Encequidar mesylate/Topotecan 相关的临床结果
100 项与 Encequidar mesylate/Topotecan 相关的转化医学
100 项与 Encequidar mesylate/Topotecan 相关的专利(医药)
100 项与 Encequidar mesylate/Topotecan 相关的药物交易